CLINICAL_TRIALS
trial_result
· 2023-01-18
Clinical Trial Update: Calorie Restriction With or Without Metformin in Triple Negative Breast Cancer [Phase 2]
Summary
Phase 2 trial update evaluating calorie restriction with or without metformin in triple-negative breast cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Triple-negative Breast Cancer | Phase 2 | Status: UNKNOWN